Healthequity (HQY) Price to FCF (2014 - 2026)

Healthequity has reported Price to FCF for 13 years, with the latest figure at 68.73 in Q3 2026.

• On a quarterly basis, Price to FCF rose 2.86% year-over-year to 68.73 in Q3 2026; TTM through Jul 2026 was 18.98, a 28.75% decrease from a year earlier, with the FY2026 full-year figure at 17.74, down 46.4% from the prior year.
• Price to FCF was 68.73 for Q3 2026 at Healthequity, down from 84.37 in the prior quarter.
• The five-year high for Price to FCF was 202.72 in Q2 2023, with the low at 801.71 in Q2 2022.
• Average Price to FCF over 5 years is 66.0, with a median of 98.09 recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Price to FCF slumped 295.54% in 2022, then surged 125.29% in 2023.
• Over 5 years, Price to FCF stood at 178.98 in 2022, then retreated by 24.46% to 135.2 in 2023, then slipped by 29.79% to 94.92 in 2024, then tumbled by 33.49% to 63.13 in 2025, then rose by 8.87% to 68.73 in 2026.
• The last three Price to FCF figures came in at 68.73 (Q3 2026), 84.37 (Q2 2026), and 67.33 (Q1 2026), per Business Quant data.